(Q27640440)

English

Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines

scientific article (publication date: 13 February 2003)

Statements

Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines (English)
0 references
0 references
0 references
Christopher S Burgey
0 references
Kyle A Robinson
0 references
Terry A Lyle
0 references
Philip E J Sanderson
0 references
S Dale Lewis
0 references
Bobby J Lucas
0 references
Julie A Krueger
0 references
Rominder Singh
0 references
Cynthia Miller-Stein
0 references
Rebecca B White
0 references
Bradley Wong
0 references
Elizabeth A Lyle
0 references
Peter D Williams
0 references
Craig A Coburn
0 references
Bruce D Dorsey
0 references
Maria T Stranieri
0 references
Marie A Holahan
0 references
Gary R Sitko
0 references
Jacquelynn J Cook
0 references
Colleen M McDonough
0 references
William M Sanders
0 references
Audrey A Wallace
0 references
Franklin C Clayton
0 references
Dennis Bohn
0 references
Yvonne M Leonard
0 references
Theodore J Detwiler
0 references
Joseph J Lynch
0 references
Youwei Yan
0 references
Zhongguo Chen
0 references
Lawrence Kuo
0 references
Stephen J Gardell
0 references
Jules A Shafer
0 references
Joseph P Vacca
0 references
13 February 2003
0 references
46
0 references
4
0 references
461-73
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit